amitriptyline has been researched along with sr 144528 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hassanzadeh, A; Hassanzadeh, P | 1 |
| Arbabi, E; Atyabi, F; Dinarvand, R; Hassanzadeh, P | 1 |
2 other study(ies) available for amitriptyline and sr 144528
| Article | Year |
|---|---|
Implication of NGF and endocannabinoid signaling in the mechanism of action of sesamol: a multi-target natural compound with therapeutic potential.
Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Antioxidants; Benzodioxoles; Brain; Camphanes; Dose-Response Relationship, Drug; Endocannabinoids; Flurazepam; Injections, Intraperitoneal; Male; Molecular Targeted Therapy; Nerve Growth Factor; Phenols; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Signal Transduction | 2013 |
The endocannabinoid system and NGF are involved in the mechanism of action of resveratrol: a multi-target nutraceutical with therapeutic potential in neuropsychiatric disorders.
Topics: Amitriptyline; Animals; Antioxidants; Brain; Camphanes; Cannabinoids; Clonazepam; Dose-Response Relationship, Drug; Endocannabinoids; Male; Nerve Growth Factor; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Resveratrol; Signal Transduction; Stilbenes | 2016 |